Your session is about to expire
← Back to Search
Behavioral Intervention
Web-Based Wellness Program for Long COVID (BLEND Trial)
N/A
Recruiting
Led By Carla Prado, PhD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Aged ≥ 18 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 8
Awards & highlights
BLEND Trial Summary
This trial aims to improve long COVID outcomes by using nutrition, mindfulness and self-care. Patients need personalized interventions to improve overall health & quality of life.
Who is the study for?
This trial is for adults over 18 with long COVID, diagnosed more than 12 weeks ago, who have a BMI between 18.5 and 35, and experience mild to moderate symptoms. They must be able to visit the study center and willing to change their lifestyle. Excluded are those with severe mobility or mental health issues, communication barriers, certain medical devices, or without internet access.Check my eligibility
What is being tested?
The trial tests a web-based platform called My Viva Plan designed for self-care in nutrition and mindfulness to improve physical function in patients with long COVID. It aims to see if this online application can help enhance overall health and quality of life for these individuals.See study design
What are the potential side effects?
Since the intervention involves non-invasive activities like nutrition guidance and mindfulness exercises through an online platform, there are no direct side effects associated with typical medications or clinical treatments.
BLEND Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
BLEND Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, week 8
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 8
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility (defined by recruitment, adherence, and retention).
Secondary outcome measures
Changes in dietary intake
Changes in fat mass
Changes in lean mass
+9 moreBLEND Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Use of My Viva Plan
Group II: Control ArmActive Control1 Intervention
No use of My Viva Plan
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
898 Previous Clinical Trials
387,443 Total Patients Enrolled
12 Trials studying COVID-19
4,538 Patients Enrolled for COVID-19
Revive Wellness Inc.UNKNOWN
2 Previous Clinical Trials
147 Total Patients Enrolled
Carla Prado, PhDPrincipal InvestigatorUniversity of Alberta
8 Previous Clinical Trials
581 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger